SciSparc Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPRC research report →
About the company
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy.
- CEO
- Oz Adler
- IPO
- 2021
- Employees
- 2
- HQ
- Tel Aviv, IL
Price Chart
- Market Cap
- $276.47K
- P/E
- -0.02
- P/S
- 0.32
- P/B
- 0.05
- EV/EBITDA
- 0.46
- Div Yield
- 0.00%
- Gross Margin
- 46.38%
- Op Margin
- -1022.08%
- Net Margin
- -1422.78%
- ROE
- -704.60%
- ROIC
- -152.55%
- Revenue
- $856.00K · -34.46%
- Net Income
- $-12,179,000 · -93.81%
- EPS
- $-882.64 · -8980.66%
- Op Income
- $-8,749,000
- FCF YoY
- 18.95%
- 52W High
- $80.10
- 52W Low
- $2.98
- 50D MA
- $7.10
- 200D MA
- $14.42
- Beta
- 2.48
- Avg Volume
- 1.09M
Get TickerSpark's AI analysis on SPRC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 1, 26 | Shrem Itschak | sell | 462 |
| Mar 18, 26 | DAYAN ALON | other | 0 |
| Mar 18, 26 | Shrem Itschak | other | 0 |
| Mar 1, 22 | Shrem Itschak | other | 6 |
| Mar 18, 26 | Shay Amnon Ben | other | 0 |
| Mar 1, 22 | Shay Amnon Ben | other | 1 |
| Mar 18, 26 | Revach Moshe | other | 0 |
| Mar 1, 22 | Revach Moshe | other | 1 |
| Mar 18, 26 | Adler Oz | other | 0 |
| Mar 1, 22 | Adler Oz | other | 6 |
Our SPRC coverage
Recent articles, reports, and earnings notes.
No research on SPRC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SPRC report →Similar companies
Peers in the same neighborhood.